For instance, B4GALT1 expression has been shown to be associated with a worse prognosis in bladder cancer, clear cell renal cell carcinomas, and pancreatic ductal adenocarcinomas [18–20]. Here, B4GALT1 is linked to pancreatic ductal adenocarcinoma.